Abstract
In the October issue of <i>Chem</i>, Piel and co-workers revealed that the biosynthetic potential for the incorporation of pharmacophoric α-keto-β-amino acids in ribosomal peptides is distributed across members of a wealth of bacterial genera. This unusual post-translational modification can potentially be applied to drug discovery and design, particularly of protease inhibitors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
